Related Experiment Video
Updated: Mar 31, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Orexin signaling is necessary for hypoglycemia-induced prevention of conditioned place preference
Oleg Otlivanchik1, Nicole M Sanders2, Ambrose Dunn-Meynell3
1Graduate School of Biomedical Sciences, Rutgers University, Newark, New Jersey; Department of Neurology, New Jersey Medical School, Rutgers University, Newark, New Jersey;
Abstract:
While the neural control of glucoregulatory responses to insulin-induced hypoglycemia is beginning to be elucidated, brain sites responsible for behavioral responses to hypoglycemia are relatively poorly understood. To help elucidate central control mechanisms associated with hypoglycemia unawareness, we first evaluated the effect of recurrent hypoglycemia on a simple behavioral measure, the robust feeding response to hypoglycemia, in rats. First, food intake was significantly, and similarly, increased above baseline saline-induced intake (1.1 ± 0.2 g; n = 8) in rats experiencing a first (4.4 ± 0.3; n = 8) or third daily episode of recurrent insulin-induced hypoglycemia (IIH, 3.7 ± 0.3 g; n = 9; P < 0.05). Because food intake was not impaired as a result of prior IIH, we next developed an alternative animal model of hypoglycemia-induced behavioral arousal using a conditioned place preference (CPP) model. We found that hypoglycemia severely blunted previously acquired CPP in rats and that recurrent hypoglycemia prevented this blunting. Pretreatment with a brain penetrant, selective orexin receptor-1 antagonist, SB-334867A, blocked hypoglycemia-induced blunting of CPP. Recurrently hypoglycemic rats also showed decreased preproorexin expression in the perifornical hypothalamus (50%) but not in the adjacent lateral hypothalamus. Pretreatment with sertraline, previously shown to prevent hypoglycemia-associated glucoregulatory failure, did not prevent blunting of hypoglycemia-induced CPP prevention by recurrent hypoglycemia. This work describes the first behavioral model of hypoglycemia unawareness and suggests a role for orexin neurons in mediating behavioral responses to hypoglycemia.
Insights
Recurrent hypoglycemia blunts behavioral responses, a key aspect of hypoglycemia unawareness. Orexin neurons play a role in these responses, offering insights into brain mechanisms.
Area of Science:
- Neuroscience
- Endocrinology
- Behavioral Science
Background:
- Neural control of glucoregulation is increasingly understood.
- Brain mechanisms of behavioral responses to hypoglycemia remain poorly understood.
- Hypoglycemia unawareness is a significant clinical concern.
Purpose of the Study:
- To investigate central control mechanisms of hypoglycemia unawareness.
- To evaluate the effect of recurrent hypoglycemia on behavioral responses.
- To establish a behavioral model for studying hypoglycemia unawareness.
Main Methods:
- Evaluated feeding response to recurrent insulin-induced hypoglycemia (IIH) in rats.
- Developed a conditioned place preference (CPP) model to assess hypoglycemia-induced behavioral arousal.
- Administered orexin receptor-1 antagonist (SB-334867A) and sertraline to assess their effects.
Main Results:
- Recurrent IIH did not impair feeding response.
- Hypoglycemia blunted previously acquired CPP, an effect prevented by recurrent hypoglycemia.
- Orexin receptor-1 antagonist blocked hypoglycemia-induced CPP blunting.
- Recurrent hypoglycemia decreased preproorexin expression in the perifornical hypothalamus.
- Sertraline did not prevent the blunting of CPP.
Conclusions:
- This study presents the first behavioral model of hypoglycemia unawareness.
- Orexin neurons are implicated in mediating behavioral responses to hypoglycemia.
- Recurrent hypoglycemia alters behavioral responses, potentially contributing to unawareness.
More Related Videos
11:10Membrane Potential Dye Imaging of Ventromedial Hypothalamus Neurons From Adult Mice to Study Glucose Sensing
Published on: November 27, 2013
08:07Simultaneous Detection of c-Fos Activation from Mesolimbic and Mesocortical Dopamine Reward Sites Following Naive Sugar and Fat Ingestion in Rats
Published on: August 24, 2016
Related Concept Videos
Regulation of Food Intake
Hypoglycemia and Glucagon
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...